SEC Form D · filed April 5, 2016
Sapience Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (14)
Robert Ruffolo, Ph.D · Scarsdale, NYDirectorIsaac Blech · Scarsdale, NYDirectorBarry Kappel, Ph.D · Scarsdale, NYExec · DirectorDavid Scheinberg, Ph.D · Scarsdale, NYDirectorHoward Pien · Hampton, NJDirectorShaun Greffard · VANCOUVER, British Columbia, CanadaExec · DirectorEd Theobald · VANCOUVER, British Columbia, CanadaDirectorIain Ball · VANCOUVER, British Columbia, CanadaDirectorSid Paquette · Toronto, Ontario, CanadaDirectorWg Depositor 5, LLC · NASHUA, NHDirectorAlbert F. Fleury · Chevy Chase, MDDirectorPatrick G. Daignault · Montreal, Quebec, CanadaDirectorMary K. Simonson · Phoenix, AZExec · DirectorHoward Pien · Scarsdale, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗